Inactive

Sole Source Award Notice: Sermo, Inc. Sermo is the only platform that provides both of the 2 key types of data collection that Center for Drug Evaluations and Research (CDER), Office of Communications... Sole Source Award Notice: Sermo, Inc. Sermo is the only platform that provides both of the 2 key types of data collection that Center for Drug Evaluations and Research (CDER), Office of Communications (OCOMM) researchers need: 1) access to an unlimited database of anonymized data in the form of real-time doctor-to-doctor discussions and patient case collaborations; and 2) ability to conduct primary research through quick-turnaround surveys among physicians, both of which are customizable to FDA needs and specifications and available on-demand 24 hours a day, seven days a week. Sermo also has the largest verified network of licensed physicians, which currently includes more than 800,000 verified doctors spanning the U.S. and more 150 other countries and is growing, providing the geographic diversity and heterogeneity that is needed for the kinds of detailed exploratory investigations CDER/OCOMM is undertaking through these online social platforms. Estimated Value: $614,937 for a base year plus four option years. A notice of intent is issued a sole source to Sermo, Inc. with authority of the FAR Part 12.603 (c)(2)(i), this is a combined synopsis/solicitation for commercial items prepared in accordance with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. and If there are no responses have received in response to the posting. Therefore, it was determined that no other sources are capable and willing to provide both of the 2 key types of data collection that Center for Drug Evaluations and Research (CDER), Office of Communications (OCOMM) researchers need: 1) access to an unlimited database of anonymized data in the form of real-time doctor-to-doctor discussions and patient case collaborations; and 2) ability to conduct primary research through quick-turnaround surveys among physicians, both of which are customizable to FDA needs and specifications and available on-demand 24 hours a day, seven days a week. In accordance with FAR Part 13.106-1(b), the Contracting Officer may solicit from one source if the Contracting Officer determines that the circumstances of the contract action deem only one source reasonably available. For the reasons stated above, Sermo, Inc. is the only source considered in this procurement.